douglas pharmaceuticals ltd graeme douglas managing director
TRANSCRIPT
Douglas Pharmaceuticals Ltd
Graeme DouglasManaging Director
Company history
Year Key Event
1967 Trading commences
1972 Frusemide registered
1983 Penicillin plant commissioned (solid oral in ‘85)
1986 Purchase of Karitane product license
1988 Loss of 3 major agencies
1989 First Australian market product registration
1990 Henderson site opened (new plant in 1996)
1996 Sale of Karicare to Nutricia
2002 Isotretinoin first registered in Europe
2006 Sale of Australian subsidiary
2007 FDA Approval
2008 Purchase of nutraceutical business line
2010 Added softgel capacity to manufacturing capabilities
Sales Growth
0
20
40
60
80
100
120
140
1967
1970
1975
1980
1985
1990
1995
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
B
CAGR 14%
Growth In Revenue 1967 – 2011B (NZ$m’s)
Product Development Process
G1
IdeasEvaluation Detailed
Scoping
Product Design
Scale-up Bio-studies Registration
& LicensingLaunch
G3G4
G5G6
G7
G2
• Company Strategy• Market Assessment• Patent Search• Feasibility• API Source
• Formulation• Analytical• Validation • Pilot Scale
• Large Scale• Validation• Stability
• Clinical• Stability
• Regulatory• Costings• Licensing• Stability
3-6 MonthsNZ$ 70K
12 - 24 MonthsNZ$0.5 to 2Mn
2-10 MonthsNZ$0.5 to 1.5Mn
6-12 MonthsNZ$0.3 to 1Mn
18-36 MonthsNZ$0.5 to 1.5Mn
TOTAL (per Project)3.5 - 7.5 years duration and NZ$ 2.0 to 6.0Mn
Continued Investment in R&D
89
104
123
139146143
7981
78
10 1012
16
21
12
0
20
40
60
80
100
120
140
160
2004 2005 2006 2007 2008 2009 2010 2011B
0
5
10
15
20
25
30
Annual Sales Annual R&D Spend
Douglas Pharmaceuticals Turnover and R&D Spend (2004 – 2011B)
NZ$M’s NZ$M’s
An
nu
al
Turn
ov
er
An
nu
al
R&
D S
pe
nd
Oratane (Isotretinoin Softgel Capsules)
• Isomer of Vitamin A acid• Highly effective treatment for Acne• Product is a challenge to develop, manufacture &
register
• Douglas developed the first generic• A huge success for Douglas: 40 customers in 26 countries• Oratane has annual sales of over NZ$ 40 million
Global Growth Accelerated Product and New Market Growth Are Key Elements of Our 2015 Growth Strategy
Key
Existing markets
New markets
Key Objectives 2010 2015
Number of Douglas Developed Products 23 45
Total Sales Revenues (Domestic and Export) $139m $250m
Thank You